Background illustration for clinical trials search

Paid Clinical Trials Pittsburgh

Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma,
Location: Pittsburgh PA, Cleveland OH, Toronto, New York NY,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT04429542

Phase 1, Recruiting

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

for
Melanoma
Location: Pittsburgh PA
Sponsor: Yana Najjar

Sex: All

Age: 18+

Code: NCT06216938

Early Phase 1, Recruiting

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

for
Estrogen Receptor Negative, HER2 Positive Breast Carcinoma,
Location: Pittsburgh PA, Voorhees Township NJ, Charlotte NC,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 30+

Code: NCT02945579

Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Pittsburgh PA, Cleveland OH, Fairfax VA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase 1, Phase 2, Recruiting

TERPS Trial for de Novo Oligometastic Prostate Cancer

for
Prostate Cancer, Oligometastatic Disease
Location: Pittsburgh PA, Columbia MD, Baltimore MD,
Sponsor: University of Maryland, Baltimore

Sex: Male

Age: 18+

Code: NCT05223803

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

for
Merkel Cell Carcinoma
Location: Pittsburgh PA, Fairfax VA, Toronto, Ann Arbor MI,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT03787602

Phase 1, Phase 2, Recruiting

Detection of Genetic Markers of Lung Cancer

for
Lung Cancer
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT00280202

Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Pittsburgh PA, Winston-Salem NC, Charlotte NC,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase 3, Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for
Solid Tumor
Location: Pittsburgh PA, Philadelphia PA, Edgewood KY, Norfolk VA,
Sponsor: ImmunoGenesis

Sex: All

Age: 18+

Code: NCT06014502

Phase 1, Recruiting

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

for
EGFRI Induced Acneiform Lesions
Location: Pittsburgh PA, Cincinnati OH, Philadelphia PA,
Sponsor: Lutris Pharma Ltd.

Sex: All

Age: 18+

Code: NCT04759664

Phase 2, Recruiting

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

for
Solid Tumor, Adult Lymphoma
Location: Pittsburgh PA, Houston TX, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05358379

Phase 1, Phase 2, Recruiting

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Pittsburgh PA
Sponsor: Olivera Finn

Sex: All

Age: 18+

Code: NCT01720836

Phase 1, Phase 2, Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for
Prostate Cancer,
Location: Pittsburgh PA, Columbus OH, Hershey PA, Baltimore MD,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase 1, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Pittsburgh PA, Columbus OH, Washington D.C. DC,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

for
Squamous Cell Carcinoma
Location: Pittsburgh PA
Sponsor: Christopher Wilke

Sex: All

Age: 18+

Code: NCT02128906

Phase 2, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Pittsburgh PA, Columbus OH, Buffalo NY, Danville PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

for
Advanced Solid Tumor
Location: Pittsburgh PA, Columbus OH, Toronto, Montreal,
Sponsor: Senhwa Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04890613

Phase 1, Recruiting

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

for
Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer,
Location: Pittsburgh PA
Sponsor: Dan Zandberg

Sex: All

Age: 18+

Code: NCT04114136

Phase 2, Recruiting

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

for
Brain Metastases, Solid Tumors
Location: Pittsburgh PA, New York city NY, Boston MA
Sponsor: Aposense Ltd.

Sex: All

Age: 18+

Code: NCT00805636

Phase 2, Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Pittsburgh PA, Buffalo NY, Hackensack NJ, Boston MA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06469281

Phase 1, Recruiting